Assignee
NOEMA PHARMA AG
CH·4 granted patents·7 pending applications·4 citations·filing 2022–2025
Top patents by PatentIndex Score
11 records- 0182US11998535B2Methods of treatment of tuberous sclerosis complexNOEMA PHARMA AG·Filed 2023·Granted Jun 4, 2024·1 cites·19 claims
- 0282US11883385B2Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndromeNOEMA PHARMA AG·Filed 2022·Granted Jan 30, 2024·2 cites·25 claims
- 0382US11684613B2Methods of treatment of tuberous sclerosis complexNOEMA PHARMA AG·Filed 2022·Granted Jun 27, 2023·1 cites·27 claims
- 0470US2025099445A1Methods of treatment of tuberous sclerosis complexNOEMA PHARMA AG·Filed 2024·Application pending·0 cites
- 0567US2026076950A1Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndromeNOEMA PHARMA AG·Filed 2025·Application pending·0 cites
- 0664US12544364B2Use of a phosphodiesterase 10 inhibitor for the treatment of tourette syndromeNOEMA PHARMA AG·Filed 2023·Granted Feb 10, 2026·0 cites·23 claims
- 0760US2023172922A1Methods of treatment of trigeminal neuralgiaNOEMA PHARMA AG·Filed 2023·Application pending·0 cites
- 0859US2025345320A1Methods of treatment of trigeminal neuralgiaNOEMA PHARMA AG·Filed 2025·Application pending·0 cites
- 0954US2023381193A1Methods for the treatment of childhood-onset fluency disorderNOEMA PHARMA AG·Filed 2023·Application pending·0 cites
- 1051US2025213526A1Triple uptake inhibitor for the treatment of atypical depressionNOEMA PHARMA AG·Filed 2023·Application pending·0 cites
- 1146US2025360120A1Methods of treatment of dravet syndromeNOEMA PHARMA AG·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOEMA PHARMA AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →